Skip to main content
Live · TradingView
Back to the NewsWire

Insidehealthpolicy

Published September 11, 2026 · Updated September 12, 2026

FDA, NIH Officials Signal Optimism On Psychedelic Therapies Ahead Of Public Meeting

Read the full story at Insidehealthpolicy

In the lead-up to FDA's public meeting Monday (Sept. 14) on development and potential future use of psychedelic treatments, senior FDA drug.

Surfaced by this Google Alert

  • Psychedelics